arrow
U

Ulrich Keller

Charite University Medical Center Berlin
H指数:86
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

改变的身体成分与接受和不接受心脏毒性治疗癌症患者中心脏消耗的关联

2026-10-070
OAAI
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial

CD19 CAR T细胞疗法治疗难治性血清阳性类风湿关节炎:一项1期临床试验

2026-08-270
PRE
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses

一种独特的CAR-T细胞表型介导了有限剂量下的治疗效果

2026-07-290
OA
Feasibility and safety of rapid glofitamab ramp-up

快速提升glofitamab的可行性与安全性

Leukemia
IF13.4
2026-07-010
OAAI
Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells

克隆性造血不影响嵌合抗原受体(CAR)T细胞的制备

2026-06-030
OAAI
Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC

基于液体活检检测获得性MET耐药性使MET融合阳性NSCLC患者能够进行序贯靶向治疗

2026-04-210
OA
Identification of MHC ligands through allele-guided isolation combined with machine learning for improved MHC assignment using ARDisplay-I

通过等位基因引导分离结合机器学习方法鉴定MHC配体,以改进使用ARDisplay-I的MHC分配

2026-03-270
OAAI
Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome
2026-01-210
OAAI
Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance (Vol 110, pg 3022, 2025)

化疗-free的ibrutinib与obinutuzumab联合治疗初治性晚期滤泡性淋巴瘤:德国淋巴瘤联盟(Vol 110, pg 3022, 2025)的一项II期研究的结果

2025-12-010
OAAI
Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance

化疗免联合伊布替尼和奥滨尤妥珠单抗治疗初治晚期滤泡性淋巴瘤:德国淋巴瘤联盟一项II期研究的结果

2025-12-012
OAAI
Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic Cancer

靶向磷脂酰肌醇-3-激酶α/δ和小泛素样修饰物信号通路之间的相互依赖性在胰腺癌中的作用

2025-10-270
OAAI
CD22 Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignancies

CD22特异性T细胞受体使B细胞恶性肿瘤的过继性T细胞疗法成为可能。

Blood
IF23.1
2025-10-210
PRE
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer Patients

虚弱及其在晚期癌症患者中的预后作用与简单FRAIL和Fried虚弱问卷的识别

2025-10-120
OAAI
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)

请提供需要翻译的英文句子。

2025-08-300
OAAI